The global AI in medical coding market size is evaluated at USD 2.63 billion in 2024, grew to USD 2.98 billion in 2025 and is projected to reach around USD 9.16 billion by 2034. The market is expanding at a CAGR of 13.30% between 2024 and 2034. The North America AI in medical coding market size is predicted to increase from USD 840 million in 2024 and is estimated to grow at a fastest CAGR of 13.31% during the forecast period.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: AI in Medical Coding Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. AI in Medical Coding Market, By Component, 2024-2034
8.1.1. In-house
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Outsourced
8.1.2.1. Market Revenue and Forecast (2021-2034)
9.1. AI in Medical Coding Market, By End User, 2024-2034
9.1.1. Healthcare providers
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Medical billing companies
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Payers
9.1.3.1. Market Revenue and Forecast (2021-2034)
10.1. North America
10.1.1. Market Revenue and Forecast, By Component (2021-2034)
10.1.2. Market Revenue and Forecast, By End User (2021-2034)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, By Component (2021-2034)
10.1.3.2. Market Revenue and Forecast, By End User (2021-2034)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, By Component (2021-2034)
10.1.4.2. Market Revenue and Forecast, By End User (2021-2034)
10.2. Europe
10.2.1. Market Revenue and Forecast, By Component (2021-2034)
10.2.2. Market Revenue and Forecast, By End User (2021-2034)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, By Component (2021-2034)
10.2.3.2. Market Revenue and Forecast, By End User (2021-2034)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, By Component (2021-2034)
10.2.4.2. Market Revenue and Forecast, By End User (2021-2034)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, By Component (2021-2034)
10.2.5.2. Market Revenue and Forecast, By End User (2021-2034)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, By Component (2021-2034)
10.2.6.2. Market Revenue and Forecast, By End User (2021-2034)
10.3. APAC
10.3.1. Market Revenue and Forecast, By Component (2021-2034)
10.3.2. Market Revenue and Forecast, By End User (2021-2034)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, By Component (2021-2034)
10.3.3.2. Market Revenue and Forecast, By End User (2021-2034)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, By Component (2021-2034)
10.3.4.2. Market Revenue and Forecast, By End User (2021-2034)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, By Component (2021-2034)
10.3.5.2. Market Revenue and Forecast, By End User (2021-2034)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, By Component (2021-2034)
10.3.6.2. Market Revenue and Forecast, By End User (2021-2034)
10.4. MEA
10.4.1. Market Revenue and Forecast, By Component (2021-2034)
10.4.2. Market Revenue and Forecast, By End User (2021-2034)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, By Component (2021-2034)
10.4.3.2. Market Revenue and Forecast, By End User (2021-2034)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, By Component (2021-2034)
10.4.4.2. Market Revenue and Forecast, By End User (2021-2034)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, By Component (2021-2034)
10.4.5.2. Market Revenue and Forecast, By End User (2021-2034)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, By Component (2021-2034)
10.4.6.2. Market Revenue and Forecast, By End User (2021-2034)
10.5. Latin America
10.5.1. Market Revenue and Forecast, By Component (2021-2034)
10.5.2. Market Revenue and Forecast, By End User (2021-2034)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, By Component (2021-2034)
10.5.3.2. Market Revenue and Forecast, By End User (2021-2034)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, By Component (2021-2034)
10.5.4.2. Market Revenue and Forecast, By End User (2021-2034)
11.1. 3M Health Information Systems
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Optum360
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. M*Modal
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. TruCode
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Cerner Corporation
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. nThrive
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Dolbey Systems, Inc.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Streamline Health
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. M-scribe Technologies
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Talix
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample